https://www.selleckchem.com/products/thal-sns-032.html ck of objective criteria for diagnosis increase the chances of medical errors and makes it an area vulnerable to litigation. INTRODUCTION Post-implantation syndrome (PIS) is the clinical and biochemical expression of an inflammatory response following endovascular aneurysm repair, with a reported incidence ranging from 2-100%. Although generally benign, some studies report an association between PIS and post-operative major adverse cardiovascular events (MACE). Nonetheless, the role of PIS in post-operative myocardial injury (MINS) is unknown. This work aims to evaluate the relation between post-implantation syndrome and MINS in a subset of EVAR patients, as well as assess the impact of PIS in all-cause mortality. METHODS All patients undergoing elective standard EVAR between January 2008 and June 2017, and with at least one measurement of contemporary (cTnI) or high sensitivity troponin I (hSTnI) in the first 48h after surgery, were retrospectively analyzed. Post-implantation syndrome was defined as the presence of fever and leukocytosis in the postoperative period in the absence of infectious complications. MINS was defined as thS was found to be significantly associated with post-operative MACE (p=0.001), but not MINS. Survival analysis revealed no differences between patients with or without PIS regarding 30-day mortality as well as long-term all-cause mortality. ASA score (HR 2.157; 95% CI 1.07 - 4.33, P=0.031) and heart failure (HR 2.284; 95% CI 1.25 - 4.18, P=0.008) were found to be independently associated with increased long-term all-cause mortality in this cohort of patients. CONCLUSION PIS is a common complication after EVAR, occurring in 11.4% of the patients from this cohort. Graft type seems to significantly affect the risk of PIS, since all reported cases occurred when polyester grafts were used. PIS did not influence 30-day or long-term survival and was found to be significantly associated with p